Loading...
Market
What will be Hims & Hers EPS for Q4 2024?
3
Resolution / Starting Odds
$0.35 or more • 25%
$0.30 to $0.34 • 25%
$0.25 to $0.29 • 25%
Less than $0.25 • 25%
Hims & Hers official Q4 2024 earnings report
Story
Hims & Hers Reports Strong Q3 Earnings with $401.6M Revenue, Raises FY24 Guidance
Nov 4, 2024, 09:18 PM
Hims & Hers Health Inc. ($HIMS) reported strong Q3 2024 earnings, with revenue soaring 77% year-over-year to $401.6 million, surpassing the estimated $382.2 million. The company posted an EPS of $0.32, significantly beating the expected $0.04. Net income reached $75.6 million, supported by a $60.8 million tax benefit. The number of subscribers increased by 44% to 2 million. Adjusted EBITDA rose to $51.1 million from $12.3 million YoY, and the gross margin stood at 79%. Hims & Hers also raised its full-year guidance, forecasting FY2024 revenue between $1.46 billion and $1.465 billion, up from the previously estimated $1.4 billion. Additionally, the company provided Q4 2024 revenue guidance of $465-470 million. The stock responded positively, rising 4% in after-hours trading.
View original story
Similar markets
Yes • 50%
No • 50%
Above $4.00 • 25%
$3.50 - $4.00 • 25%
$3.00 - $3.49 • 25%
Below $3.00 • 25%
Above $0.50 • 25%
$0.41 to $0.50 • 25%
$0.31 to $0.40 • 25%
Below $0.31 • 25%
Below €1.00 • 25%
Between €1.00 and €1.25 • 25%
Between €1.25 and €1.50 • 25%
Above €1.50 • 25%
Below €1.50 • 25%
Between €1.50 and €1.60 • 25%
Between €1.60 and €1.70 • 25%
Above €1.70 • 25%
Less than €1.20 • 25%
€1.20 to €1.29 • 25%
€1.30 to €1.39 • 25%
€1.40 or more • 25%
Below $1.00 • 25%
$1.00 to $1.10 • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Less than $0.05 • 25%
$0.05 to $0.10 • 25%
$0.10 to $0.15 • 25%
More than $0.15 • 25%
Less than $0.04 • 25%
$0.04 to $0.05 • 25%
$0.06 to $0.07 • 25%
More than $0.07 • 25%
Below $6.50 • 25%
$6.50 - $6.99 • 25%
$7.00 - $7.49 • 25%
$7.50 or above • 25%
Below $0.40 • 25%
$0.40 to $0.50 • 25%
$0.51 to $0.60 • 25%
Above $0.60 • 25%